M. Kathleen Behrens

M. Kathleen Behrens is a declared insider at 3 companies (board member); the most frequent names are IGM Biosciences, Inc., Sarepta Therapeutics, Inc. and Mimedx Group, Inc. In total, 36 filings cover trades dated from 27 May 2021 to 4 June 2026.

The open-market record is one-sided, with 2 purchases worth €1.9M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 27 share grants and 5 option exercises.

The latest filing, published on 5 June 2026, reports a share grant in Sarepta Therapeutics, Inc. The clock since the last published purchase (28 June 2023) now reads 1,208 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.